Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT05323123
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- SPARK — BEHAVIORALSPARK is delivered in a clinic setting by a counselor using motivational interviewing techniques (e.g., open-ended questions, affirmations).
- HealthMpowerment — BEHAVIORALPrEP adherence support app that utilizes engaging social networking and game-based elements, with an in-app portal for individualized live adherence counseling.
- PrEP Education — BEHAVIORALEducational information about PrEP provided by physician during medical visits.
Study Details
To stem increasing rates of HIV among gay and bisexual men in Central-Eastern Europe, the feasibility, acceptability, and early efficacy of a culturally adapted evidence-based program to introduce pre-exposure prophylaxis (PrEP) into Romania's healthcare practice will be established. PrEP Romania, a hybrid in-person + mHealth PrEP uptake and adherence program, aims to empower gay and bisexual men and their healthcare system to adopt PrEP and support adherence. Findings can inform evidence-based PrEP rollout in other Central-Eastern European countries with similar levels of unpreparedness for biomedical prevention.
Key Dates
- Start date
- Oct 1, 2021
- Status verified
- Oct 2025
- Primary completion
- Sep 30, 2024
- Completion
- Nov 30, 2024
Study Design
- Enrollment
- 120 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: PrEP RomaniaParticipants will receive PrEP (as part of their standard of care), motivational counseling, and PrEP adherence support.
- Active Comparator: ControlParticipants will receive PrEP (as part of their standard of care) and PrEP education during medical visits.
Primary Outcome Measure
PrEP Adherence Via Biological Measures (Binary) [ Time Frame: Measured at 3 months post-baseline and 6 months post-baseline ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University School of Nursing | New York | New York | 10032 | - |
Find similar trials in New York, NY
Related Studies
- Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman DiseaseRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Cefixime Clinical TrialPHASE3 · Recruiting · University of Southern California · Los Angeles, California
- Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive DonorsRecruiting · Tulane University · Metairie, Louisiana